Amprius Technologies, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AMPX research report →
Range $18 – $24
Price Chart
About the company
Amprius Technologies, Inc. is a company primarily focused on the development, production, and supply of advanced lithium-ion battery solutions. Their innovative product line notably includes cutting-edge silicon nanowire anode lithium-ion batteries.
- CEO
- Thomas Michael Stepien
- IPO
- 2022
- Employees
- 97
- HQ
- Fremont, CA, US
AI snapshot
Six angles, distilled from the data.
The stock remains in a damaged downtrend, trading well below its 200-day average after a long slide from the 52-week high. It is still above the 52-week low, so the setup is more of a rebound attempt than a confirmed trend reversal.
Street sentiment stays constructive, with a Buy consensus and a $20 median target versus a $9.61 last close. Recent action has been mostly reiterations and target resets in the $18-$24 range, which keeps the longer-term upside case intact despite the weak share price.
The earnings profile is still mixed: the company has beaten in 5 of the last 7 quarters, but the two most recent reports missed or matched expectations. Next-year EPS is still only around $0.10, so shareholders should watch whether revenue growth can keep translating into margin improvement.
Recent insider activity leans clearly negative on the discretionary side, with multiple open-market sales from the CEO, a director, and the CTO. The award and gift entries are noise, but the cluster of sales from senior leadership suggests management has been reducing exposure rather than adding to it.
Profitability is still weak, but the top line is growing fast. Revenue rose 125.9% year over year, while gross margin was 22.3%, operating margin was -12.6%, and net margin was -33.4%. The balance sheet is a plus, with $90.5 million in cash and $50.6 million in net cash.
AMPX stands out for growth and balance-sheet strength, but it still lags established industrial peers on profitability and scale. The valuation remains rich for a loss-making name, with a negative P/E and a market cap of about $1.36 billion.
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.34B
- P/E
- -32.51
- Fwd P/E
- 201.06
- PEG
- 10.54
- P/S
- 12.25
- P/B
- 10.79
- EV/EBITDA
- -37.26
- Div Yield
- 0.00%
- Gross Margin
- 22.25%
- Op Margin
- -17.05%
- Net Margin
- -35.16%
- ROE
- -34.75%
- ROIC
- -14.11%
Latest fiscal year · YoY change
- Revenue
- $73.01M+202.1%
- Gross Profit
- $8.26M+145.1%
- Op Income
- $-46,646,000
- Net Income
- $-44,024,000+1.4%
- EPS
- $-0.35+22.2%
- OCF Growth
- +6.7%
- FCF Growth
- +2.8%
- 52W High
- $24.23
- 52W Low
- $7.71
- 50D MA
- $10.14
- 200D MA
- $13.44
- Beta
- 2.34
- RSI (14)
- 43
- Avg Volume
- 5.63M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Amprius posted another record quarter on strong drone-related demand, raised full-year revenue and margin guidance again, and said it is progressing toward NDAA-compliant U.S. supply.· August 5, 2026
- Q2 revenue hit a record $34 million, up 19% sequentially and 2.3x year over year.
- Gross margin improved to 27% from 20% in Q1 and 9% a year ago, while adjusted EBITDA narrowed to negative $1 million.
- Management raised 2026 guidance again to at least $140 million of revenue and at least 28% gross margin, while reaffirming more than $4 million of adjusted EBITDA.
- Defense drone demand remained a major driver, with a $24 million European drone order, broader adoption of SiCore, and half of 19 drone dominance finalists using Amprius cells.
- The company emphasized capital-light scaling through contract manufacturers in China, South Korea, and the U.S., with full U.S. NDAA-compliant cells still targeted for 2027.
Q2 revenue was $34 million, up 19% sequentially and 2.3x year over year; first-half revenue was $62.6 million, up 137% year over year. Gross profit was $9.3 million and gross margin was 27%, versus 20% in Q1 and 9% in the same quarter last year; first-half gross margin was 24% versus negative 4% in the first half of 2025. GAAP net loss attributable to common shareholders was $5.1 million, or negative $0.04 per share, and adjusted net loss was $3.2 million, or negative $0.02 per share; adjusted EBITDA was negative $1 million. Cash ended at $74.5 million with no debt, up $12.2 million in the quarter. For 2026, management now expects at least $140 million of revenue, at least 28% gross margin, more than $4 million of adjusted EBITDA, net loss of $10 million or less, and loss of $0.08 or less per diluted share.
Tom Stepien framed the quarter as evidence that Amprius is gaining real traction in energy-dense silicon-anode batteries, especially for drones and other mobility applications. He emphasized broadening end markets — defense UAVs, commercial delivery, robotics, satellites, eVTOL, and e-mobility — while highlighting the company’s “capital-efficient” contract manufacturing model. His tone was optimistic and expansionary, but he repeatedly noted that some newer markets are early and still need customer qualification and execution.
Ricardo Rodriguez focused on the financial execution: revenue of $34 million, gross margin of 27%, operating loss of $4.3 million, net loss of $5.1 million, and adjusted EBITDA of negative $1 million. He pointed to a strong cash position of $74.5 million, no debt, and only $2.9 million of cash used in operations, while noting inventory and receivables were intentionally built to support the second-half ramp. He also said capex was $1.8 million in Q2, first-half capex was $2.8 million, and the company is tracking below its less than $10 million full-year capex expectation. On guidance, he said revenue visibility improved, tariff-related costs and Colorado-related expenses helped make the margin raise easier, and the company expects at least 28% gross margin in the second half while keeping SG&A growth controlled.
Analysts focused on NDAA compliance, U.S. manufacturing capacity, drone-demand visibility, margins, and how quickly new markets like robotics, delivery drones, and data centers could contribute. Management said supplier qualification for NDAA is progressing and that they expect to have the new suppliers under contract this quarter, while still targeting fully U.S. NDAA-compliant cells in 2027. On margins, Ricardo said the main drivers are product and regional mix, with accretive sales, pouch-cell mix, and Europe helping, but he warned there could still be quarter-to-quarter lumpiness as the company absorbs the cost structure needed for NDAA compliance. They also said they are actively exploring additional U.S. partner manufacturing, including pouch-cell capacity, but are not ready to announce specifics yet.
The bull case from this call is that demand is clearly accelerating, led by drones and other high-energy-density applications, and management now has enough visibility to raise guidance for the second straight quarter. The company is also moving toward a larger, more flexible manufacturing footprint without heavy capital spending, which could support further margin expansion if mix stays favorable.
The main risks are execution and timing: management said supplier contracts, U.S. NDAA-compliant capacity, and new market ramp-ups still require work and may take quarters to turn into revenue. They also cautioned that margins may not move in a straight line because NDAA compliance, regional mix shifts, and fixed-cost absorption can create quarterly lumpiness, especially as the business scales.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 92.9%
- Shares Outstanding
- 141.63M
- Float Shares
- 131.61M
of shares held by institutions
268 13F filers
Buy/sell ratio 0.13. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 11.34M | ▲ 2.11M |
| Vanguard Group Inc | 7.13M | ▲ 616.04K |
| Vanguard Capital Management LLC | 5.56M | ▲ 654.11K |
| Morgan Stanley | 5.11M | ▲ 1.94M |
| Two Sigma Investments, LP | 4.32M | ▲ 812.55K |
| Ubs Group AG | 4.07M | ▲ 1.76M |
| Geode Capital Management, LLC | 3.52M | ▲ 706.13K |
| Jane Street Group, LLC | 3.40M | ▼ 759.59K |
| State Street Corp | 3.24M | ▲ 527.65K |
| Goldman Sachs Group Inc | 2.54M | ▲ 316.11K |
| Jupiter Asset Management Ltd | 2.13M | ▲ 2.13M |
| Lmr Partners Llp | 1.75M | ▲ 1.75M |
Held by 270 ETFs
Biggest fund positions in AMPX by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 21, 26 | Sun Kang | sell | 62,101 |
| Aug 21, 26 | Stefan Constantin Ionel | sell | 29,681 |
| Aug 21, 26 | Stepien Thomas M | sell | 23,529 |
| Aug 24, 26 | Stepien Thomas M | sell | 8,000 |
| Aug 25, 26 | Stepien Thomas M | other | 5,000 |
| Aug 25, 26 | Stepien Thomas M | other | 5,000 |
| Aug 25, 26 | Stepien Thomas M | other | 5,000 |
| Aug 25, 26 | Stepien Thomas M | other | 346 |
| Aug 25, 26 | Stepien Thomas M | other | 346 |
| Jun 12, 26 | BAYLESS KATHLEEN A | other | 10,423 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our AMPX coverage
Recent articles, reports, and earnings notes.

Elon’s Missing Pieces, Revealed: Every Stock Dr. Skousen Is Teasing in Skousen Wealth Network
Dr. Skousen and The Oxford Club are pitching the Skousen Wealth Network through “Elon’s Missing Pieces.” We identify the three stocks and test the claims against filings.

ATII Holdings SPAC Merger: The Bull and Bear Case
ATII Holdings is going public through a merger with Archimedes Tech SPAC Partners II Co. (ticker ATII), with the combined company expected to trade as NANO. The bull case is a strategic AI-chip and battery materials platform backed by Samsung SDI; the bear case is a still-early business facing redemption risk, dilution, and a going-concern warning.

Best Lithium Battery Stocks for September 2026: 7 Picks
A seven-stock countdown spanning lithium materials, battery developers, commercial-vehicle systems, home storage and mature consumer batteries.
Want a deeper read on AMPX?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
CAMINUS Signs Contract Manufacturing Agreement with Amprius Technologies for U.S. Pouch Cell Production
prnewswire.com · Oct 5
The Bull Case for Amprius Technologies Just Got Stronger
marketbeat.com · Sep 30
Amprius Secures $75 Million Grant for American High-Energy Density Battery Production
gurufocus.com · Sep 28
Amprius Secures $75 Million Grant for American High-Energy Density Battery Production
businesswire.com · Sep 28
Amprius Technologies: U.S. Drone Dominance Will Help, But It Has Many Attractive End Markets
seekingalpha.com · Sep 19
Amprius Introduces SiCore®500 – High Energy Density Cells for Unmanned Aviation
businesswire.com · Sep 2
Amprius Sets September 2026 Events Schedule
businesswire.com · Sep 1
AMPX Q2 Earnings Call Highlights Higher Guidance and Drone Demand
zacks.com · Aug 7
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
AI analysis · Last refreshed October 2, 2026 · Live quote · Not investment advice